Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

72.36
+0.12000.17%
Volume:749.40K
Turnover:54.21M
Market Cap:11.27B
PE:62.38
High:72.39
Open:72.27
Low:72.27
Close:72.24
52wk High:72.62
52wk Low:43.20
Shares:155.81M
Float Shares:155.81M
Volume Ratio:0.63
T/O Rate:0.48%
Dividend:0.32
Dividend Rate:0.44%
EPS(TTM):1.16
EPS(LYR):1.16
ROE:9.03%
ROA:6.26%
PB:5.35
PE(LYR):62.38

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Bio-Techne (TECH)

TIPRANKS
·
May 07

Bio-Techne reports Q3 adjusted EPS 53c, consensus 53c

TIPRANKS
·
May 07

U.S. RESEARCH ROUNDUP-ARM Holdings, CDW, Doordash

Reuters
·
May 07

Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and InMode (INMD)

TIPRANKS
·
May 07

Bio-Techne Down Over 15%, on Pace for Largest Percent Decrease Since October 2000 -- Data Talk

Dow Jones
·
May 07

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
May 07

BUZZ-Bio-Techne down after quarterly revenue misses estimates

Reuters
·
May 06

Stock Track | Bio-Techne Plummets 5.64% Intraday After Missing Q3 Revenue and Earnings Estimates

Stock Track
·
May 06

Bio-Techne misses revenue estimates as US academic funding cuts dent demand

Reuters
·
May 06

Bio-Techne Q3 revenue misses estimates, hurt by order timing

Reuters
·
May 06

Bio-Techne Q3 FY26 GAAP EPS rises to $0.32; revenue drops 2% to $311.4 million

Reuters
·
May 06

Bio-Techne Q3 Adj. EPS $0.53 Misses $0.54 Estimate, Sales $311.415M Miss $317.093M Estimate

Benzinga Earnings
·
May 06

Bio-Techne declares quarterly dividend of $0.08 per share

Reuters
·
May 06

BRIEF-Bio-Techne Q3 Adjusted EPS USD 0.53 Vs. IBES Estimate USD 0.54

Reuters
·
May 06

Bio-Techne Q3 EPS USD 0.32

THOMSON REUTERS
·
May 06

Bio-Techne Q3 Operating Expenses USD 132.793 Million

THOMSON REUTERS
·
May 06

Bio-Techne Releases Third Quarter Fiscal 2026 Results

THOMSON REUTERS
·
May 06

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 06

Assessing Bio-Techne (TECH) Valuation After Mixed Long Term Shareholder Returns

Simply Wall St.
·
May 06

Bio-Techne CEO Kelderman to present at Bank of America Securities Global Healthcare Conference

Reuters
·
May 04